Recent Analysts’ Ratings Changes for Colgate-Palmolive (CL)

Several brokerages have updated their recommendations and price targets on shares of Colgate-Palmolive (NYSE: CL) in the last few weeks:

• 10/19/2026 – Colgate-Palmolive had its price target raised by JPMorgan Chase & Co. from $103.00 to $104.00. They now have an “overweight” rating on the stock.
• 10/15/2026 – Colgate-Palmolive was given a new $106.00 price target by UBS Group.
• 10/9/2026 – Colgate-Palmolive had its price target lowered by Bank of America from $102.00 to $100.00. They now have a “buy” rating on the stock.
• 10/8/2026 – Colgate-Palmolive had its price target raised by Evercore from $100.00 to $101.00. They now have an “outperform” rating on the stock.
• 10/5/2026 – Colgate-Palmolive had its price target lowered by Wells Fargo & Company from $95.00 to $90.00. They now have an “equal weight” rating on the stock.
• 10/2/2026 – Colgate-Palmolive was downgraded by Weiss Ratings from “buy (b-)” to “hold (c+)”.
• 9/28/2026 – Colgate-Palmolive had its price target lowered by BNP Paribas Exane from $101.00 to $97.00. They now have an “outperform” rating on the stock.
• 9/21/2026 – Colgate-Palmolive had its price target lowered by Piper Sandler from $98.00 to $95.00. They now have an “overweight” rating on the stock.
• 9/16/2026 – Colgate-Palmolive was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 9/8/2026 – Colgate-Palmolive had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $104.00 price target on the stock.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be issued a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.3%. The ex-dividend date is Tuesday, October 20th.

Insiders Place Their Bets

In other news, Director John T. Cahill sold 4,170 shares of the business’s stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the sale, the director owned 28,373 shares in the company, valued at $2,649,187.01. The trade was a 12.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Noel R. Wallace sold 161,021 shares of the business’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the sale, the chief executive officer owned 362,231 shares in the company, valued at $33,296,273.52. This represents a 30.77% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 175,191 shares of company stock worth $16,110,903. Company insiders own 0.43% of the company’s stock.

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.